Technical Analysis for GHRS - GH Research PLC

Grade Last Price % Change Price Change
A 23.035 -3.82% -0.92
GHRS closed up 2.05 percent on Tuesday, December 7, 2021, on 2.69 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Down
Historical GHRS trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish -3.82%
Stochastic Buy Signal Bullish -3.82%
NR7 Range Contraction -3.82%
Wide Bands Range Expansion -3.82%
Oversold Stochastic Weakness -3.82%
20 DMA Resistance Bearish -1.85%
Crossed Above 50 DMA Bullish -1.85%
Pocket Pivot Bullish Swing Setup -1.85%
Volume Surge Other -1.85%
Lower Bollinger Band Walk Weakness -1.85%
Older End-of-Day Signals for GHRS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 4 minutes ago
10 DMA Support 18 minutes ago
Down 3% 31 minutes ago
Down 2 % 31 minutes ago
Fell Below 20 DMA 31 minutes ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that is being investigated in the Phase 2 part of an ongoing Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate that is in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was founded in 2018 and is based in Dublin, Ireland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Psychoactive Drugs Entheogens Treatment Resistant Depression Psychiatric And Neurological Disorders N N Dimethyltryptamine

Is GHRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.43
52 Week Low 12.76
Average Volume 142,183
200-Day Moving Average 0.00
50-Day Moving Average 21.30
20-Day Moving Average 23.79
10-Day Moving Average 23.41
Average True Range 3.40
ADX 39.06
+DI 19.77
-DI 13.53
Chandelier Exit (Long, 3 ATRs) 20.22
Chandelier Exit (Short, 3 ATRs) 29.47
Upper Bollinger Bands 27.48
Lower Bollinger Band 20.10
Percent B (%b) 0.52
BandWidth 31.02
MACD Line 0.33
MACD Signal Line 0.66
MACD Histogram -0.3333
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.23
Resistance 3 (R3) 28.10 26.55 27.51
Resistance 2 (R2) 26.55 25.46 26.61 27.27
Resistance 1 (R1) 25.25 24.79 25.90 25.38 27.04
Pivot Point 23.70 23.70 24.03 23.76 23.70
Support 1 (S1) 22.40 22.61 23.05 22.53 20.86
Support 2 (S2) 20.85 21.94 20.91 20.63
Support 3 (S3) 19.55 20.85 20.39
Support 4 (S4) 19.68